| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
|
Lancet
|
2013
|
8.18
|
|
2
|
Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.
|
J Immunol
|
2008
|
3.19
|
|
3
|
Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies.
|
J Immunol Methods
|
2004
|
2.50
|
|
4
|
Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents.
|
Am J Respir Crit Care Med
|
2012
|
2.32
|
|
5
|
Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.
|
J Immunol
|
2008
|
2.27
|
|
6
|
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.
|
Eur J Immunol
|
2010
|
2.25
|
|
7
|
Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
|
J Infect Dis
|
2011
|
2.24
|
|
8
|
Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis.
|
PLoS One
|
2012
|
2.09
|
|
9
|
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
|
J Infect Dis
|
2008
|
2.05
|
|
10
|
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults.
|
Am J Respir Crit Care Med
|
2010
|
2.03
|
|
11
|
Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases.
|
BMC Infect Dis
|
2007
|
1.72
|
|
12
|
Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy.
|
Int J Infect Dis
|
2008
|
1.66
|
|
13
|
The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants.
|
J Infect Dis
|
2006
|
1.64
|
|
14
|
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review.
|
BMC Infect Dis
|
2013
|
1.57
|
|
15
|
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.
|
Vaccine
|
2009
|
1.45
|
|
16
|
The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa.
|
PLoS One
|
2011
|
1.42
|
|
17
|
Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response.
|
J Immunol
|
2006
|
1.40
|
|
18
|
Strengthening the expanded programme on immunization in Africa: looking beyond 2015.
|
PLoS Med
|
2013
|
1.32
|
|
19
|
A prospective, cross-sectional study of anaemia and peripheral iron status in antiretroviral naïve, HIV-1 infected children in Cape Town, South Africa.
|
BMC Infect Dis
|
2002
|
1.32
|
|
20
|
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.
|
Am J Respir Crit Care Med
|
2013
|
1.31
|
|
21
|
Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.
|
Clin Infect Dis
|
2009
|
1.28
|
|
22
|
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews.
|
BMC Public Health
|
2012
|
1.20
|
|
23
|
Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis.
|
BMC Med
|
2009
|
1.14
|
|
24
|
HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.
|
J Infect Dis
|
2009
|
1.12
|
|
25
|
'Communicate to vaccinate' (COMMVAC). building evidence for improving communication about childhood vaccinations in low- and middle-income countries: protocol for a programme of research.
|
Implement Sci
|
2011
|
1.12
|
|
26
|
A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.
|
Am J Respir Crit Care Med
|
2012
|
1.09
|
|
27
|
Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease.
|
Vaccine
|
2010
|
1.03
|
|
28
|
Growth and micronutrient disturbances in stable, HIV-infected children in Cape Town.
|
Ann Trop Paediatr
|
2002
|
1.01
|
|
29
|
The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa.
|
Pediatr Infect Dis J
|
2006
|
0.99
|
|
30
|
Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome.
|
Pediatr Infect Dis J
|
2004
|
0.94
|
|
31
|
A bibliometric analysis of childhood immunization research productivity in Africa since the onset of the Expanded Program on Immunization in 1974.
|
BMC Med
|
2013
|
0.94
|
|
32
|
Making BCG vaccination programmes safer in the HIV era.
|
Lancet
|
2008
|
0.90
|
|
33
|
Understanding interventions for improving routine immunization coverage in children in low- and middle-income countries: a systematic review protocol.
|
Syst Rev
|
2013
|
0.89
|
|
34
|
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol.
|
Syst Rev
|
2013
|
0.89
|
|
35
|
Review of rotavirus studies in Africa: 1976-2006.
|
J Infect Dis
|
2010
|
0.89
|
|
36
|
Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa.
|
J Paediatr Child Health
|
2007
|
0.88
|
|
37
|
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol.
|
BMJ Open
|
2014
|
0.88
|
|
38
|
Incidence and Diagnosis of Pertussis in South African Children Hospitalized With Lower Respiratory Tract Infection.
|
Pediatr Infect Dis J
|
2016
|
0.88
|
|
39
|
Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.
|
BMC Infect Dis
|
2012
|
0.87
|
|
40
|
Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life.
|
Clin Immunol
|
2008
|
0.87
|
|
41
|
Developing vaccinology expertise for Africa: six years and counting.
|
Vaccine
|
2011
|
0.84
|
|
42
|
Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin.
|
Pediatr Infect Dis J
|
2002
|
0.83
|
|
43
|
The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative.
|
Pan Afr Med J
|
2011
|
0.83
|
|
44
|
Lessons and myths in the HIV/AIDS response.
|
Lancet
|
2009
|
0.81
|
|
45
|
Trends in the types and quality of childhood immunisations research output from Africa 1970-2010: mapping the evidence base.
|
BMC Health Serv Res
|
2014
|
0.80
|
|
46
|
HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load.
|
AIDS Res Hum Retroviruses
|
2011
|
0.77
|
|
47
|
Use of systematic reviews in WHO recommendations.
|
Lancet
|
2011
|
0.77
|
|
48
|
Knowledge, attitudes and practices on adolescent vaccination among parents, teachers and adolescents in Africa: a systematic review protocol.
|
Syst Rev
|
2014
|
0.75
|
|
49
|
Safety of licensed vaccines in HIV-infected persons: a systematic review protocol.
|
Syst Rev
|
2014
|
0.75
|
|
50
|
The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children.
|
Pediatr Infect Dis J
|
2015
|
0.75
|
|
51
|
Public stewardship of private for-profit healthcare providers in low- and middle-income countries.
|
Cochrane Database Syst Rev
|
2016
|
0.75
|
|
52
|
SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosis.
|
S Afr Med J
|
2012
|
0.75
|